Factor This Power Engineering
Live Events
DTECH® Events
POWERGENâ¢
Calendar
Webinars
Podcasts
Contribute Content
Solar
Community
Residential
Utility Scale
Wind Power
Offshore
Turbines & Equipment
Power Grid
Distribution
Grid Modernization
Microgrids
Outage Management
Smart Grids
Transmission
Hydropower
Dams & Civil Structures
Small Hydropower
Technology & Equipment
Tidal & Wave Energy
Energy Storage
Battery
Long Duration
Pumped Storage
Business
Finance
Policy & Regulation
Project Development
Tariffs
Electric Vehicles
EV Charging
Vehicle to Grid
Subscribe
Solar
Community
Residential
Utility Scale
Wind Power
Offshore
Turbines & Equipment
Power Grid
Distribution
Grid Modernization
Microgrids
Outage Management
Transmission
Smart Grids
Hydropower
Dams & Civil Structures
Small Hydro
Technology & Equipment
Tidal & Wave Energy
Energy Storage
Battery
Long Duration
Pumped Storage
Business
Finance
Policy & Regulation
Electric Vehicles
EV Charging
Vehicle to Grid
Factor This: Power Engineering
Live Events
DISTRIBUTECH®
Podcasts
Webinars
Calendar
Contribute Content
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
EL&P Market Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
BioLineRx Ltd. - American Depositary Shares
(NQ:
BLRX
)
3.380
+0.120 (+3.68%)
Streaming Delayed Price
Updated: 3:59 PM EST, Dec 5, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about BioLineRx Ltd. - American Depositary Shares
< Previous
1
2
3
4
5
6
7
8
Next >
Dow Jumps Over 300 Points; US Industrial Production Beats Estimates
↗
January 17, 2025
Via
Benzinga
Topics
Stocks
Why Taiwan Semiconductor Shares Are Trading Higher By Around 5%; Here Are 20 Stocks Moving Premarket
↗
January 16, 2025
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
↗
January 06, 2025
Via
Benzinga
Nasdaq Surges Over 200 Points; BioLineRx Shares Plummet
↗
January 06, 2025
Via
Benzinga
Earnings Preview For BioLine Rx
↗
November 22, 2024
Via
Benzinga
BLRX Stock Earnings: BioLine Rx Beats Revenue for Q2 2024
↗
August 15, 2024
BLRX stock results show that BioLine Rx beat on revenue for the second quarter of 2024.
Via
InvestorPlace
Earnings Preview For BioLine Rx
↗
March 25, 2024
Via
Benzinga
BioLine Rx Earnings Preview
↗
November 17, 2023
Via
Benzinga
S&P Jumps 1%; Regional Health Properties Shares Spike Higher
↗
January 06, 2025
Via
Benzinga
Topics
Stocks
US Stocks Open Higher; Dow Jumps Over 200 Points
↗
January 06, 2025
Via
Benzinga
Topics
Stocks
Why Check-Cap Shares Are Trading Higher By Over 52%; Here Are 20 Stocks Moving Premarket
↗
January 03, 2025
Via
Benzinga
Earnings Scheduled For November 25, 2024
↗
November 25, 2024
Via
Benzinga
HC Wainwright & Co. Maintains Buy Rating for BioLine Rx: Here's What You Need To Know
↗
September 15, 2023
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
↗
November 21, 2024
Via
Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
↗
October 11, 2024
Via
Benzinga
Why Arcadium Lithium Shares Are Trading Higher By 28%; Here Are 20 Stocks Moving Premarket
↗
October 07, 2024
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
↗
June 18, 2024
It's time to start the day with a breakdown of the biggest pre-market stock movers worth keeping an eye on for Tuesday morning!
Via
InvestorPlace
Millionaire Makers: 7 Stocks You Can Buy for $2 That Can 10X by 2025
↗
June 05, 2024
These 10X penny stocks have the potential to mint millionaires with enough capital but buy wisely as the risk is real.
Via
InvestorPlace
BLRX Stock Earnings: BioLine Rx Beats EPS for Q1 2024
↗
May 28, 2024
BLRX stock results show that BioLine Rx beat analyst estimates for earnings per share the first quarter of 2024.
Via
InvestorPlace
BLRX Stock Earnings: BioLine Rx Beats EPS for Q4 2023
↗
March 26, 2024
BLRX stock results show that BioLine Rx beat analyst estimates for earnings per share the fourth quarter of 2023.
Via
InvestorPlace
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
↗
March 26, 2024
Via
Benzinga
Biotech/Oncology Stocks Targeting the Pancreatic Cancer Market – A Race Worth
March 06, 2024
EQNX::TICKER_START (ONASDAQ:ONCY),(TSX:ONC),(NASDAQ:BLRX),(NASDAQ:IMRX),(NASDAQ:CADL) EQNX::TICKER_END
Via
FinancialNewsMedia
Earnings Scheduled For March 26, 2024
↗
March 26, 2024
Companies Reporting Before The Bell • bluebird bio (NASDAQ:BLUE) is likely to report quarterly loss at $0.66 per share on revenue of $16.68 million.
Via
Benzinga
3 Top Penny Stocks for 5,000% Upside in 2024 and Beyond
↗
February 25, 2024
When you want to light your afterburners, these ideas will do the trick.
Via
InvestorPlace
Earnings Scheduled For November 20, 2023
↗
November 20, 2023
Companies Reporting Before The Bell • Greenland Technologies (NASDAQ:GTEC) is projected to report quarterly earnings at $0.05 per share on revenue of $24.26 million.
Via
Benzinga
Week In Review: Hengrui Out-Licenses Next-Gen PARP1 To Merck KGaA For $1.7 Billion
↗
November 04, 2023
Jiangsu Hengrui Pharma out-licensed global rights for its next-gen PARP1 inhibitor to Germany’s Merck KGaA for a $170 million upfront payment and up to $1.5 billion in milestones. Merck will have...
Via
Talk Markets
3 Tech Stocks That Wall Street Loves More Than Nvidia
↗
November 02, 2023
Purchase these top tech stocks now to achieve maximum profits and allow your portfolio to skyrocket given the volatile market.
Via
InvestorPlace
3 Top Penny Stocks to Make You a Millionaire in 5 Years
↗
October 30, 2023
Penny stocks can make you a millionaire with patience and luck especially when you follow secular trends overall.
Via
InvestorPlace
BioLineRx Touts Encouraging Data From Therapy Trial For First Line Pancreatic Cancer
↗
September 28, 2023
BioLineRx Ltd (NASDAQ: BLRX) announced data from the single-arm pilot phase of the investigator-initiated CheMo4METPANC Phase 2 combination trial of motixafortide and gemcitabine and nab-paclitaxel...
Via
Benzinga
Unity Software To Rally Around 60%? Here Are 10 Other Analyst Forecasts For Friday
↗
September 15, 2023
B of A Securities raised the price target for Unity Software Inc. (NYSE: U) from $46 to $56. B of A Securities analyst Ryan Gee upgraded the stock from Neutral to Buy. Unity Software shares fell 3% to...
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
